|
Gene affected | Human syndrome | Human cardiac phenotype | Mutation and/or expression in BAV patients | Mouse valve phenotype | Reference |
|
NOTCH1 | | BAV, calcification, BAV with aortic aneurysm | R1108X, H1505del, T596M, P179H, A1343V, P1390T | Thick valve leaflets, calcification | [21ā23] |
GATA6 | | ASD, TOF | Mother of the ASD patient had a BAV | No valve phenotype reported | [26] |
FBN1 | Marfan syndrome | Mitral valve prolapse, Aortic aneurysm | Reduced expression of FBN1 | Thick and long valve leaflets, mitral valve prolapse | [28ā31] |
TGFBR2 | Loeys-Dielz syndrome, Marfan syndrome | Mitral valve prolapse, aortic aneurysm, BAV | V387M | Defective remodelling of the AV cushion, lethality at E11.5 precluding analysis of valves | [36] |
ACTA2 | | Thoracic aortic aneurysm and dissection | Three family members had a BAV | No valve phenotype | [38] |
HOXA1 | Bosley-Salih-Alorainy syndrome, athabascan brainstem dysgenesis syndrome | Interrupted aortic arch type B, aberrant subclavian artery, VSD, TOF, BAV | Not reported | BAV | [39] |
KCNJ2 | Andersen syndrome | BAV, BAV with coarctation of the aorta, pulmonary stenosis | R67W | Not reported | [41] |
|